| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |